SCHEDULE 13G 0002101709 XXXXXXXX LIVE Class A Ordinary Shares, par value $0.0001 per share 12/29/2025 0001855644 Zura Bio Limited G9TY5A101 1489 W. Warm Springs Road #110 Henderson NV 89014 Rule 13d-1(c) Athanor Capital E9 0.00 11581402.00 0.00 11581402.00 11581402.00 N 15.7 CO UGS Capital LLC DE 0.00 11581402.00 0.00 11581402.00 11581402.00 N 15.7 OO Zura Bio Limited 1489 W. Warm Springs Road #110, Henderson, NV, 89014 This statement is filed on behalf of: (1) Athanor Capital and (2) UGS Capital LLC. The foregoing persons are individually referred to as a "Reporting Person" and hereinafter collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which such Reporting Persons have agreed to file this Schedule 13G and all subsequent amendments to the Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the Class A Ordinary Shares reported herein. From June 22, 2023 until May 21, 2025, Mr. Parvinder Thiara, a director of Athanor Capital and a Manager of UGS Capital LLC, was a member of the board of directors of the Issuer. The principal business address of each of the Reporting Persons is: (1) 2578 Broadway, #593, New York, NY 10025 (2) 850 New Burton Road, Suite 201, Dover, DE, 19904 (1) Athanor Capital is an Exempted Company incorporated in the Cayman Islands with Limited Liability (2) UGS Capital LLC is a limited liability company organized under the laws of the State of Delaware Y The information required by Item 4(a) is set forth in Rows 5 through 9 of the cover pages for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(b) is set forth in Row 11 of the cover pages for each of the Reporting Persons and is incorporated herein by reference. The percentage set forth in this Schedule 13G is based on 73,680,710 Class A Ordinary Shares that the Issuer has advised the Reporting Persons were issued and outstanding as of the filing date of this report. The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Y Y Y N Athanor Capital owns the Class A Ordinary Shares of the Issuer. UGS Capital LLC owns all the shares of Athanor Capital. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 1 - Joint Filing Agreement Athanor Capital /s/ Parvinder Thiara 01/02/2026 UGS Capital LLC /s/ Parvinder Thiara 01/02/2026